Test Price
2,800 AED✅ Home Collection Available
ADA2 Gene (CECR1) Genetic Testing for DADA2 & Sneddon Syndrome in Dubai, UAE
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS and bioinformatics pipeline aligned with current reference genomes.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance including genetic counseling to clarify result implications.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This next‑generation sequencing assay comprehensively analyses the entire ADA2 (formerly CECR1) gene to identify pathogenic variants underlying Deficiency of Adenosine Deaminase 2 (DADA2), a treatable autosomal recessive autoinflammatory vasculitis often presenting as Sneddon syndrome.
| Feature | Our ADA2 NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Gene Coverage | Full gene – all exons, intron/exon boundaries, promoter region | Select exons only; may miss deep intronic or regulatory variants |
| Methodology | NGS (Illumina® platform) with ISO‑validated bioinformatics | Capillary (Sanger) sequencing |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Price | 2800 AED (all-inclusive) | ~3500 AED |
Physician Insight & Safety Protocols
“A genetic diagnosis of DADA2 can dramatically alter management; early recognition prevents strokes. However, this test must always be interpreted together with your complete clinical picture — a negative result does not exclude all mimics, and a variant of uncertain significance warrants expert correlation. I support you in discussing each finding with your treating physician.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Safety Advisory
Do not discontinue prescribed medication without consulting your doctor. Test results may influence therapy but never replace acute clinical decisions.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals who have not completed pre‑test genetic counseling or who cannot provide informed consent (for minors, parental consent is mandatory per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- ER Red Flags: Sudden severe headache, focal weakness, facial droop, speech difficulty, or new skin ulceration — call 998 (UAE Ambulance) immediately; these may indicate an acute stroke or vasculitic crisis.
Patient FAQ & Clinical Guidance
1. What does the ADA2 gene test detect?
This genetic test identifies disease‑causing mutations in the entire ADA2 gene, confirming Deficiency of Adenosine Deaminase 2 (DADA2), a recessively inherited autoinflammatory vasculitis that can mimic Sneddon syndrome with livedo racemosa, early‑onset strokes, and systemic inflammation.
2. How should I prepare for the test?
No fasting or special preparation is required; a certified phlebotomist collects a single blood sample during your scheduled home visit, while mandatory pre‑ genetic counseling ensures you understand the implications of possible results.
3. How long until results arrive and what do they mean?
Results are ready within 3 to 4 weeks; a positive pathogenic variant confirms DADA2 and often directs biologic therapy (anti‑TNF), while a negative report significantly reduces DADA2 probability but does not exclude other genetic stroke syndromes.
UAE Regulatory & Data Privacy Adherence
Compliance & Data Protection
- DHA / MOHAP Approved Laboratory Facility
- Compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Adhering to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Clinical safety and patient consent governed by Federal Decree-Law No. 4 of 2016 on Medical Liability
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139)
Clinical & Logistical Metadata
| Test Name | ADA2 Gene (CECR1) Full Sequencing |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | E79.8 |
| LOINC Code | 92879-2 |
| DHA Facility License & Laboratory Address | DHA License: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians